SmD2 Acetylation Rewires PARP Sensitivity in HCC

2026-09-11

This study identifies acetylation-dependent control of the spliceosome protein SmD2 as a regulatory link between alternative splicing, BRCA1/FANC DNA repair, and PARP inhibitor sensitivity in hepatocellular carcinoma. Its preclinical findings support combining spliceosome-directed strategies with PARP inhibition, particularly in tumors without canonical BRCA1/2 defects.

Gap26 in Astrocyte–Cx43 Pain Signaling

2026-09-11

Gap26 is a connexin 43 mimetic peptide for dissecting astrocyte-mediated communication in breakthrough cancer pain. This article translates recent spinal EAAT–Cx43 findings into practical assay design, controls, and cross-domain research decisions.

JNJ-26481585 (Quisinostat) in Tumor Research

2026-09-10

JNJ-26481585 (Quisinostat) combines high-potency HDAC inhibition with a practical route for studying apoptosis, proliferation, and treatment resistance. This workflow-focused guide connects epigenetic readouts with the TRIM21–ERK1/2 axis identified in pituitary adenoma research.

Salvianolic acid B: From Target to Matrix

2026-09-10

Salvianolic acid B (Dan Shen Suan B) is a research probe for connecting LH2 expression with collagen architecture in pulmonary fibrosis. This article presents a matrix-centered assay framework that separates reduced collagen abundance from altered cross-linking, epithelial–mesenchymal transition, and extracellular matrix remodeling.

Carbenoxolone disodium: Practical Lab Guide

2026-09-09

Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best used as an exploratory cell or tissue perturbation reagent with vehicle, viability, and orthogonal controls, not as a selective in vivo efficacy agent or definitive target-validation compound.

EZ Cap™ Cy5 Firefly Luciferase mRNA: Lab Guide

2026-09-09

This scenario-based guide explains how EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), SKU R1010, can separate mRNA uptake from productive translation in delivery, viability, and cytotoxicity workflows. It covers optical readouts, experimental controls, handling, interpretation, and practical vendor-selection criteria.

Carbenoxolone disodium: Practical Lab Guide

2026-09-08

Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid handling, corticosterone metabolism, and gap junction communication. Use it as a mechanistic research tool with matched vehicle, formulation, viability, and orthogonal pathway controls; do not treat it as a selective in vivo efficacy compound without additional validation.

Cyclic di-GMP, HipH, and Biofilm Persistence

2026-09-08

Liao et al. identify cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. Their findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, expanding the mechanistic framework for biofilm resilience.

NVP-BGJ398 Phosphate: Context-First FGFR Assays

2026-09-07

NVP-BGJ398 phosphate is a potent FGFR1–3 inhibitor for genotype-aware pathway research. This article explains how to interpret its oncology and skeletal-disease evidence through a context-first assay strategy rather than a conventional workflow summary.

Caffeic Acid Phenethyl Ester in Fyn–NF-κB Models

2026-09-07

Caffeic Acid Phenethyl Ester (CAPE) provides a focused way to interrogate the NF-κB branch of Fyn-driven neuroinflammation. This article translates zebrafish neurodegeneration findings into a practical, branch-resolved assay strategy while distinguishing evidence-supported use from experimental extension.

M344 Histone Deacetylase Inhibitor Workflows

2026-09-05

Build more interpretable epigenetic experiments with M344 by linking dose, exposure time, viability, apoptosis, and differentiation readouts. This workflow-focused guide covers breast cancer, neuroblastoma, medulloblastoma, radiation-sensitization, formulation, and troubleshooting decisions.

RNA Pol II Loss and Apoptotic Signaling

2026-09-04

Curcumin, PBDE-47, and NET Formation

2026-09-04

The reference study identifies PBDE-47 as an inducer of neutrophil extracellular traps and links this response to Nrf2-associated reactive oxygen species. Its findings suggest that curcumin can suppress toxicant-associated NET formation, while the imaging and biochemical workflow provides a useful framework for studying pollutant–immune interactions.

Angiotensin II Workflows for Fibrosis Research

2026-09-03

Build reproducible Angiotensin II experiments that connect GPCR signaling with vascular remodeling, oxidative stress, and renal fibrotic pathways. This practical guide combines cell-based stimulation, translational animal-model considerations, and troubleshooting informed by a RIG-I–c-Myc fibrosis study.

CAPE in the Fyn–Stat3–NF-κB Axis

2026-09-03

Caffeic Acid Phenethyl Ester (CAPE) offers translational researchers a selective chemical probe for testing the NF-κB arm of Fyn-driven neuroinflammation. By connecting the 2024 zebrafish study of Fyn, Stat3, and NF-κB with practical CAPE workflows, this article frames the compound as a mechanistic decision tool rather than a stand-alone therapeutic claim.